California Seeks Paramount Divestitures in Warner Bros. Merger 
J.P. Morgan Upgrades Diploma, Lifts Price Target to 8,250p 
Luxshare Shares Rise as First-Half Profit Jumps 18% 
Unifor Reaches Tentative GM Deal for 4,600 Ontario Workers 
Trump Buys SpaceX Shares After Record IPO 
Australia’s Big Four Banks Face Mortgage Slowdown as Valuations Draw Scrutiny 
Samsung Shares Tumble 8% as $79 Billion Return Plan Disappoints 
Tesla Raises Cybertruck Prices by $5,000 in US 
SEC Probes Banks Over Situational Awareness Hedge Fund Collapse 
Apple Cuts Over 200 Siri, Vision Pro Jobs in AI Shift 
Ampol Profit Surges as Refining Margins Hit Record Highs 
Shein Launches $1.77 Billion Hong Kong IPO After Years of Listing Delays 
KPMG Australia Cuts 5% of Workforce Amid Scandal 
Tokio Marine Eyes Multibillion-Dollar Suncorp Takeover 
SoftBank Plans Record $6.3 Billion Bond Sale to Fund OpenAI Investments 
Alibaba Raises $10.2 Billion to Expand AI Infrastructure 
SK Hynix Shares Fall as Workers Reject Wage Deal 
Add as a preferred source on Google
CHICAGO, May 01, 2018 -- Lumere, a leading provider of data-driven analytics, evidence and expert guidance to help health systems reduce unwarranted clinical variation, today announced plans to collaborate with the Association of Healthcare Value Analysis Professionals’ (AHVAP) Industry Business Education Collaborative agreement.
This agreement includes educational offerings highlighting best-practice strategies and tactics to help health systems and value analysis professionals consistently apply evidence to clinical decisions. “Hospitals and clinicians are strapped to find the time and the resources to collect the vast amounts of available drug and device information and also to dissect and separate unbiased sources from biased ones,” said Lumere Chief Development Officer Gina Thomas, RN, MBA. “AHVAP is the perfect collaborator because of its dedication to applying a clinical and evidence-based perspective to the clinical decision process.”
According to AHVAP President Susan Knapp, RN, MS, CVAHP, the two organizations share a vision to improve patient value by reducing unnecessary clinical variation and reducing costs. “Variation in care is a major contributor to wasteful healthcare spending,” she said. “Our members have the potential to play important roles in curtailing that waste, and solutions like Lumere’s offer important resources for them and their facilities.”
According to Knapp, redefining and repositioning the role of value analysis offers an exceptional opportunity to bring about real change.
“Historically, value analysis leaders have had to react quickly to market place pressures. While that doesn’t change, integrating a clinical and evidence-based approach metric into all decisions will help advance the value analysis practice,” Knapp said.
Thomas, agrees with that assessment. “Our educational offerings will emphasize the fact that value analysis must be embedded within an organization’s clinical care governance as a patient-centered, multidisciplinary approach,” she said.
About Lumere
Lumere is at the forefront of clinical decision making for drugs and devices, offering evidence-based solutions and services for all providers that improve care and reduce cost across the patient journey. For more information, visit lumere.com, find us on LinkedIn, follow @LumereHQ on Twitter and like us on Facebook.
About AHVAP
The Association of Healthcare Value Analysis Professionals (AHVAP) is an organization of professionals whose expertise bridges the gap between clinical and supply chain process. Through the use of evidence, clinical and financial expertise value analysis facilitators play a pivotal role to ensure effective decision-making that positively impacts clinical, operational and financial outcomes. For more information, visit AHVAP.org, find us on LinkedIn, follow @AHVAP on Twitter and like us on Facebook.
Media Contact
Pam Flores
[email protected]
(773) 218-9260
